Account
DDB MudraMax wins media duties of Bausch and Lomb India
MUMBAI: Following a multi-agency pitch, DDB MudraMax has bagged the media duties of the US eye health product giant – Bausch and Lomb.
DDB MudraMax would be partnering with the Bausch & Lomb for their ATL media planning and strategy requirements. The agency will also utilize its expert approach, analysis, understanding of consumer and value proposition to further strengthen the position of the brand in the Indian market.
Vision Care at Bausch & Lomb business unit head – Indranil Chakravarty added, “The contact lens user base is low in India due to various myths and perceptions which are far from reality. It is perceived as difficult to wear, uncomfortable and above all costly. Bausch & Lomb is trying to grow the category by targeting the bottom of pyramid by introducing iConnect which at INR 200 p.m is the most affordable lens in its category. This will redefine the entry level prices for contact lens user in India. Bausch and Lomb is the category leader in India and through mass communication we are trying to expand the category and create awareness. We are happy to partner with DDB MudraMax and are banking heavily on their expertise to spread our communication far and deep amongst our target segments and geographies.”
Bausch & Lomb India SAARC – MD Sanjay Bhutani said, “Contact Lens industry in India is at a very nascent stage with penetration rate of around 6% of the population requiring vision correction. As a market leader it becomes our responsibility to grow the category through increasing penetration and reach with more market appropriate products.”
DDB MudraMax-Media EVP Tarun Nigam said “Bausch & Lomb was looking at a very specific set of interventions for their brand. This assumed greater importance as the brand has been absent from mass-media for the last few years. The win is a result of an amalgam between strategy and creative media application, to ensure best possible message targeting.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
